Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto N Miranda

Showing results (161-170 of 225) with videos related to

Pageof 23
Sort By:
The American Journal of Surgical Pathology|July 25, 2022
MUM1/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy: Potential Utility in Diagnosis and Differential DiagnosisSofia Garces, Zbigniew Rudzki, C Cameron Yin, et al.
British Journal of Haematology|July 1, 2015
TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosisSanam Loghavi, Alyaa Al-Ibraheemi, Zhuang Zuo, et al.
The American Journal of Surgical Pathology|November 24, 2016
Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell LymphomasE Dean Merrill, Rose Agbay, Roberto N Miranda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an updateSofia Garces, C Cameron Yin, Roberto N Miranda, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Morphologic and Molecular Characteristics of De Novo AML With <i>JAK2</i> V617F MutationJuliana E Hidalgo-López, Rashmi Kanagal-Shamanna, L Jeffrey Medeiros, et al.
Cancer|April 19, 2012
Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapyJorge J Castillo, Michael Furman, Brady E Beltrán, et al.
Leukemia & Lymphoma|December 20, 2024
Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature reviewKaren Amelia Nahmod, Roberto N Miranda, Francisco Vega, et al.
Plastic and Reconstructive Surgery. Global Open|September 28, 2020
Breast Implant-associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National RegistryCarlos Andres Ossa Gomez, Jose Fernando Robledo Abad, Alejandro Duque, et al.
Cytometry. Part B, Clinical Cytometry|September 26, 2022
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursorsHong Fang, Sa A Wang, M James You, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2017
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical courseZhihong Hu, Yi Sun, Ellen J Schlette, et al.
Pageof 23

Showing results (161-170 of 225) with videos related to

Sort By:
Pageof 23
The American Journal of Surgical Pathology|July 25, 2022
MUM1/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy: Potential Utility in Diagnosis and Differential DiagnosisSofia Garces, Zbigniew Rudzki, C Cameron Yin, et al.
British Journal of Haematology|July 1, 2015
TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosisSanam Loghavi, Alyaa Al-Ibraheemi, Zhuang Zuo, et al.
The American Journal of Surgical Pathology|November 24, 2016
Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell LymphomasE Dean Merrill, Rose Agbay, Roberto N Miranda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an updateSofia Garces, C Cameron Yin, Roberto N Miranda, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Morphologic and Molecular Characteristics of De Novo AML With <i>JAK2</i> V617F MutationJuliana E Hidalgo-López, Rashmi Kanagal-Shamanna, L Jeffrey Medeiros, et al.
Cancer|April 19, 2012
Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapyJorge J Castillo, Michael Furman, Brady E Beltrán, et al.
Leukemia & Lymphoma|December 20, 2024
Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature reviewKaren Amelia Nahmod, Roberto N Miranda, Francisco Vega, et al.
Plastic and Reconstructive Surgery. Global Open|September 28, 2020
Breast Implant-associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National RegistryCarlos Andres Ossa Gomez, Jose Fernando Robledo Abad, Alejandro Duque, et al.
Cytometry. Part B, Clinical Cytometry|September 26, 2022
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursorsHong Fang, Sa A Wang, M James You, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2017
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical courseZhihong Hu, Yi Sun, Ellen J Schlette, et al.
Pageof 23